State Street’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.01B | Sell |
10,288,696
-52,770
| -0.5% | -$17.3M | 0.1% | 177 |
|
|
2025
Q4 | $3.63B | Sell |
10,341,466
-4,703
| -0% | -$1.59M | 0.12% | 139 |
|
|
2025
Q3 | $3.34B | Sell |
10,346,169
-222,811
| -2% | -$69.3M | 0.12% | 150 |
|
|
2025
Q2 | $4.11B | Sell |
10,568,980
-78,723
| -0.7% | -$31.7M | 0.15% | 124 |
|
|
2025
Q1 | $4.63B | Sell |
10,647,703
-34,590
| -0.3% | -$13.9M | 0.19% | 98 |
|
|
2024
Q4 | $3.94B | Sell |
10,682,293
-5,705
| -0.1% | -$2.39M | 0.16% | 112 |
|
|
2024
Q3 | $5.56B | Buy |
10,687,998
+129,709
| +1% | +$69.3M | 0.23% | 75 |
|
|
2024
Q2 | $5.72B | Buy |
10,558,289
+78,528
| +0.7% | +$41.5M | 0.25% | 71 |
|
|
2024
Q1 | $5.43B | Buy |
10,479,761
+70,144
| +0.7% | +$34.9M | 0.24% | 74 |
|
|
2023
Q4 | $4.91B | Sell |
10,409,617
-38,378
| -0.4% | -$17.7M | 0.24% | 78 |
|
|
2023
Q3 | $4.55B | Sell |
10,447,995
-533,777
| -5% | -$242M | 0.25% | 72 |
|
|
2023
Q2 | $4.88B | Buy |
10,981,772
+18,387
| +0.2% | +$8.48M | 0.26% | 74 |
|
|
2023
Q1 | $5.04B | Sell |
10,963,385
-63,598
| -0.6% | -$30.3M | 0.28% | 67 |
|
|
2022
Q4 | $5.66B | Buy |
11,026,983
+221,359
| +2% | +$112M | 0.33% | 57 |
|
|
2022
Q3 | $4.91B | Sell |
10,805,624
-29,986
| -0.3% | -$14.3M | 0.31% | 60 |
|
|
2022
Q2 | $5.23B | Buy |
10,835,610
+207,417
| +2% | +$103M | 0.31% | 65 |
|
|
2022
Q1 | $5.22B | Sell |
10,628,193
-104,602
| -1% | -$47.8M | 0.26% | 77 |
|
|
2021
Q4 | $4.98B | Buy |
10,732,795
+162,857
| +2% | +$68.5M | 0.24% | 83 |
|
|
2021
Q3 | $3.94B | Buy |
10,569,938
+24,064
| +0.2% | +$9.15M | 0.21% | 87 |
|
|
2021
Q2 | $4.03B | Buy |
10,545,874
+150,930
| +1% | +$57.7M | 0.21% | 87 |
|
|
2021
Q1 | $3.73B | Sell |
10,394,944
-337,978
| -3% | -$109M | 0.21% | 90 |
|
|
2020
Q4 | $3.45B | Sell |
10,732,922
-192,727
| -2% | -$59.1M | 0.21% | 90 |
|
|
2020
Q3 | $2.93B | Sell |
10,925,649
-175,561
| -2% | -$47.2M | 0.2% | 93 |
|
|
2020
Q2 | $2.92B | Buy |
11,101,210
+179,010
| +2% | +$47.8M | 0.21% | 91 |
|
|
2020
Q1 | $2.48B | Sell |
10,922,200
-113,689
| -1% | -$31M | 0.22% | 95 |
|
|
2019
Q4 | $3.33B | Sell |
11,035,889
-72,317
| -0.7% | -$19.9M | 0.23% | 90 |
|
|
2019
Q3 | $2.67B | Sell |
11,108,206
-122,518
| -1% | -$33.6M | 0.2% | 102 |
|
|
2019
Q2 | $3.17B | Sell |
11,230,724
-103,550
| -0.9% | -$28.3M | 0.24% | 85 |
|
|
2019
Q1 | $3.25B | Buy |
11,334,274
+409,378
| +4% | +$118M | 0.25% | 82 |
|
|
2018
Q4 | $2.87B | Buy |
10,924,896
+68,429
| +0.6% | +$18.8M | 0.26% | 82 |
|
|
2018
Q3 | $2.98B | Buy |
10,856,467
+670,920
| +7% | +$174M | 0.23% | 88 |
|
|
2018
Q2 | $2.42B | Sell |
10,185,547
-203,305
| -2% | -$47.1M | 0.2% | 98 |
|
|
2018
Q1 | $2.28B | Sell |
10,388,852
-547,157
| -5% | -$129M | 0.19% | 106 |
|
|
2017
Q4 | $2.46B | Sell |
10,936,009
-31,597
| -0.3% | -$6.73M | 0.2% | 101 |
|
|
2017
Q3 | $2.08B | Sell |
10,967,606
-283,095
| -3% | -$53.9M | 0.18% | 113 |
|
|
2017
Q2 | $2.12B | Sell |
11,250,701
-111,745
| -1% | -$20.1M | 0.19% | 111 |
|
|
2017
Q1 | $1.88B | Buy |
11,362,446
+328,727
| +3% | +$52.3M | 0.17% | 129 |
|
|
2016
Q4 | $1.59B | Buy |
11,033,719
+402,925
| +4% | +$54M | 0.15% | 141 |
|
|
2016
Q3 | $1.33B | Buy |
10,630,794
+232,960
| +2% | +$30.1M | 0.13% | 165 |
|
|
2016
Q2 | $1.37B | Sell |
10,397,834
-29,604
| -0.3% | -$4.05M | 0.15% | 145 |
|
|
2016
Q1 | $1.45B | Sell |
10,427,438
-165,948
| -2% | -$22.2M | 0.16% | 131 |
|
|
2015
Q4 | $1.48B | Sell |
10,593,386
-98,876
| -0.9% | -$13.6M | 0.16% | 128 |
|
|
2015
Q3 | $1.5B | Sell |
10,692,262
-211,373
| -2% | -$31.8M | 0.17% | 120 |
|
|
2015
Q2 | $1.79B | Sell |
10,903,635
-581,266
| -5% | -$92.9M | 0.19% | 109 |
|
|
2015
Q1 | $1.77B | Sell |
11,484,901
-581,397
| -5% | -$82.8M | 0.18% | 118 |
|
|
2014
Q4 | $1.52B | Buy |
12,066,298
+113,173
| +0.9% | +$14M | 0.15% | 143 |
|
|
2014
Q3 | $1.43B | Sell |
11,953,125
-830
| -0% | -$95.2K | 0.15% | 139 |
|
|
2014
Q2 | $1.29B | Sell |
11,953,955
-92,228
| -0.8% | -$9.5M | 0.14% | 159 |
|
|
2014
Q1 | $1.2B | Sell |
12,046,183
-851,401
| -7% | -$77M | 0.14% | 161 |
|
|
2013
Q4 | $1.19B | Buy |
12,897,584
+137,607
| +1% | +$12.2M | 0.13% | 164 |
|
|
2013
Q3 | $1.07B | Sell |
12,759,977
-64,956
| -0.5% | -$5.57M | 0.13% | 165 |
|
|
2013
Q2 | $1.05B | Buy |
+12,824,933
| New | +$960M | 0.14% | 151 |
|
Other funds holding ELV
VCM
VPM
State Street's ELV Position: Q1 2026 in Review
State Street reduced its Elevance Health (ELV) stake by 0.51% in Q1 2026, selling an estimated $17.3M and leaving 10,288,696 shares worth $3.01B. The position accounts for 0.1% of the portfolio, ranked #177.
State Street first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.72B in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- State Street held 10,288,696 shares of Elevance Health worth $3.01B as of Q1 2026.
- State Street sold 52,770 Elevance Health shares in Q1 2026, an estimated $17.3M.
- Elevance Health made up 0.1% of State Street's portfolio in Q1 2026, its #177 holding.
- State Street first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- State Street's Elevance Health position peaked at $5.72B in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.